- Arrowhead Pharmaceuticals (NASDAQ:ARWR): Q2 GAAP EPS of -$0.26 misses by $0.16.
- Revenue of $32.81M (+39.6% Y/Y) misses by $6.61M.
- Press Release
Arrowhead Pharmaceuticals EPS misses by $0.16, misses on revenue
Recommended For You
About ARWR Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ARWR | - | - |
Arrowhead Pharmaceuticals, Inc. |